B-Raf positive rates were 76.56% in colon cancer (Table 1; Figures 1(b2), 1(c2), 1(d2), and 1(e2)) and 25% in para-carcinoma specimens (Table 1; Figure 1(a2)). This evidence concerns the gene BRAF and malignant colon neoplasm.